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PCardiac Surgery
ff-Pump Coronary Artery Surgery
or Reducing Mortality and Morbidity
eta-Analysis of Randomized and Observational Studies
uminda N. Wijeysundera, MD,* W. Scott Beattie, MD, PHD,* George Djaiani, MD,*
ivek Rao, MD, PHD,† Michael A. Borger, MD, PHD,† Keyvan Karkouti, MD, MSC,*‡
obert J. Cusimano, MD†
oronto, Ontario, Canada
OBJECTIVES The purpose of this study was to assess the effects of off-pump coronary bypass surgery
(OPCAB) on mortality and morbidity.
BACKGROUND Despite its potential for reducing morbidity and mortality, OPCAB’s role in clinical practice
remains controversial.
METHODS A meta-analysis of 37 randomized controlled trials (RCTs) (n  3,449) and 22 risk-adjusted
(logistic regression or propensity-score) observational studies (n  293,617) was performed.
Two reviewers performed literature searches (MEDLINE, EMBASE, PubMed, reference
lists), quality assessment, and data extraction. Treatment effects were calculated as odds ratios
(ORs) with 95% confidence intervals (CIs).
RESULTS In RCTs, OPCAB was associated with reduced atrial fibrillation (OR 0.59; 95% CI 0.46 to
0.77) and trends toward reduced 30-day mortality (OR 0.91 95% CI 0.45 to 1.83), stroke
(OR 0.52; 95% CI 0.25 to 1.05), and myocardial infarction (OR 0.79; 95% CI 0.50 to 1.25).
Observational studies showed OPCAB to be associated with reduced 30-day mortality (OR
0.72; 95% CI 0.66 to 0.78), stroke (OR 0.62; 95% CI 0.55 to 0.69), infarction (OR 0.66; 95%
CI 0.50 to 0.88), and atrial fibrillation (OR 0.78; 95% CI 0.74 to 0.82). At one to two years,
OPCAB was associated with trends toward reduced mortality, but also increased repeat
revascularization (RCT: OR 1.75, 95% CI 0.78 to 3.94; Observational: OR 1.35, 95% CI
0.76 to 2.39).
CONCLUSIONS Randomized controlled trials did not find, aside from atrial fibrillation, the statistically
significant reductions in short-term mortality and morbidity demonstrated by observational
studies. These discrepancies might be due to differing patient-selection and study method-
ology. Future studies must focus on improving research methodology, recruiting high-risk
patients, and collecting long-term data. (J Am Coll Cardiol 2005;46:872–82) © 2005 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.064the American College of Cardiology Foundation
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Monventional coronary artery bypass surgery (CCAB) is
ssociated with mortality and morbidity (1). Components
hat might contribute to these adverse events include car-
iopulmonary bypass (CPB) and aortic cross-clamping.
lthough CPB allows for construction of anastomoses in a
loodless and motionless surgical field, it generates a sys-
emic inflammatory response and microemboli (2). Further-
ore, cross-clamping of the aorta leads to atheromatous
acroembolization, which is associated with adverse out-
omes (3).
Increased awareness of CCAB’s adverse effects has re-
ewed interest in off-pump coronary artery bypass surgery
OPCAB). In OPCAB, anastomoses are performed on a
eating heart without CPB, thereby avoiding the latter’s
nherent risks. In particular, OPCAB might prevent adverse
From the *Department of Anesthesia, Toronto General Hospital, Toronto,
ntario, Canada; †Division of Cardiac Surgery, Toronto General Hospital, Toronto,
ntario, Canada; and the ‡Department of Health Policy Management and Evalua-
ion, University of Toronto, Toronto, Ontario, Canada. Drs. Wijeysundera, Rao, and
arkouti are supported in part by the Canadian Institutes of Health Research.T
Manuscript received February 22, 2005; revised manuscript received May 15, 2005,
ccepted May 31, 2005.erebral events. Off-pump coronary artery bypass surgery,
owever, carries its own risks: intraoperative hemodynamic
nstability and inadequate revascularization (4). Given the
aucity of large randomized trials showing OPCAB to cause
ignificant effects on important outcomes, OPCAB’s role in
linical practice remains controversial (5).
Therefore, we performed a systematic review to address
his uncertainty about OPCAB’s benefits. This review
ocused on randomized controlled trials (RCTs) and obser-
ational studies that statistically adjusted for differences
etween patients who underwent OPCAB as opposed to
CAB.
Our study had four objectives: to estimate OPCAB’s
ffects within RCTs and observational studies; to describe
ifferences between the study types with regard to treatment
ffects; to identify deficiencies in published reports; and to
ake suggestions about the design of future studies.
ETHODShis review adhered to the QUOROM recommendations (6).
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September 6, 2005:872–82 Meta-Analysis of Off-Pump Coronary Artery Surgeryearch strategy. Two reviewers searched MEDLINE
1966 to June 2004), EMBASE (1980 to June 2004), and
ubMed (up to June 30, 2004) for RCTs comparing
PCAB against CCAB. The text words employed were
ff-pump, beating heart, OPCAB, OPCABG, MIDCAB,
IDCABG, without extra-corporeal circulation, and without
ardiopulmonary bypass. Included trials had to report any of
he following outcomes: death, stroke, myocardial infarc-
ion, atrial fibrillation, or acute renal failure.
The same reviewers searched MEDLINE, EMBASE,
nd PubMed for observational studies reporting risk-
djusted effects of OPCAB on any of the same outcomes.
cceptable risk-adjustment methods included multivariable
ogistic regression or propensity score techniques. The text
ords and Medical Subject Headings employed were
ff-pump, beating heart, OPCAB, OPCABG, MIDCAB,
IDCABG, without extra-corporeal circulation, without car-
iopulmonary bypass, logistic models (explode), multivariate
nalysis (explode), risk adjustment (explode), regression analysis
explode), multivariable, multivariate, multiple logistic, ad-
ust$, and propensity. Bibliographies of included articles were
lso searched. No language restrictions were applied.
We employed several strategies to avoid duplicate publi-
ations. If the same institution produced multiple studies,
e only considered studies reporting recruitment time
eriods. If there was sample overlap between studies, we
ncluded only the largest study. In the case of observational
tudies, the possibility of including overlapping patients
Abbreviations and Acronyms
CCAB  conventional coronary artery bypass surgery
CI  confidence interval
CPB  cardiopulmonary bypass
OPCAB  off-pump coronary artery bypass surgery
OR  odds ratio
RCT  randomized controlled trialFigure 1. Search results. RCT xists when centers analyze their own data and also contrib-
te them to national databases. We assessed the influence of
uch duplicate reporting by analyzing results from small
10 centers) and large (10 centers) databases separately.
uality assessment and data abstraction. Two reviewers
erformed quality assessment and data abstraction. Ran-
omized controlled trial quality was rated with regard to
andomization, allocation concealment, blinded outcome
ssessment, and dropouts. Risk-adjusted observational stud-
es were evaluated on the basis of suggested criteria (7).
Data were abstracted on death, stroke, infarction, atrial
brillation, acute renal failure, inotropic support, low output
yndrome, red cell transfusion, re-operation for bleeding,
epeat revascularization (one year), and bypass graft number.
e accepted the outcome definitions used by the original
esearchers. All disagreements were resolved by consensus.
nalyses. We employed Review Manager 4.2.7 (Cochrane
ollaboration, Oxford, United Kingdom) to combine treat-
ent effects among studies with the same design. All
nalyses were performed on an intention-to-treat basis.
ffects on dichotomous outcomes were expressed as odds
atios (ORs) with 95% confidence intervals (CIs). For
bservational studies, adjusted ORs were logarithmically
ransformed and combined with the weighted inverse vari-
nce method. Continuous outcomes were expressed as
eighted mean differences with 95% CIs. Heterogeneity
as assessed with the Q-statistic. In the absence of signif-
cant heterogeneity, treatment effects were pooled with the
xed-effects model. If there was significant heterogeneity
p  0.1), the random-effects model was used; in addition,
e performed post-hoc analyses to explain the heterogene-
ty. Statistical significance was defined by p  0.05.
ensitivity analyses. The sensitivity analyses assessed the
nfluence of included studies and statistical models. The first
nalysis assessed the influence of study quality. In the case of
CTs, meta-analyses were repeated among studies report-
ng allocation concealment. Meta-analyses were also re-randomized controlled trial.
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Meta-Analysis of Off-Pump Coronary Artery Surgery September 6, 2005:872–82eated among high-quality observational studies that em-
loyed prospective data, reported ORs with CIs, specified
ariables that were considered for inclusion, described the
ariable selection process, and had 10 outcome events per
redictor variable. The second analysis examined the influ-
nce of the statistical model. Analyses that employed the
xed-effects model were repeated with the random-effects
odel.
ESULTS
he search yielded fifty-nine studies (Fig. 1). Thirty-seven
CTs (3,449 patients) were included (Table 1) (8–43). A
ingle paper reported the results of two trials, which were
nalyzed separately (9). The short- and mid-term outcomes
f two other RCTs were reported in separate publications
32,37,44,45).
Twenty-two observational studies (293,617 patients)
ere included (Table 2) (46–67). The short- and mid-term
utcomes of the same sample were reported in separate
ublications (63,64). In the case of two other cohorts,
PCAB’s association with different outcomes was reported
n separate publications (51,52,61,66). The quality of mul-
ivariable modeling was variable (Table 3).
hort-term outcomes. Ten RCTs reported 1 death
ithin 30 days of surgery, with an incidence of 1.7%
n  29) (Table 4) (9,12,13,16,24–26,29,32,35). Off-pump
oronary artery bypass surgery was associated with essen-
ially no change in mortality (OR 0.91; 95% CI 0.45 to
.83). Fourteen observational studies reported adjusted
ffects on short-term mortality (46,47,49,50,53–55,57,59–
3,65). These studies showed that OPCAB was associated
ith significantly reduced short-term mortality (OR 0.72;
5% CI 0.66 to 0.78).
The number of RCTs reporting 1 stroke was 12, with an
ncidence of 1.3% (n 27) (9,12,24–26,28,29,32,33,35,37).
ff-pump coronary artery bypass surgery was associated
ith a reduction in stroke that bordered on statistical
ignificance (OR 0.51; 95% CI 0.25 to 1.05). In the fifteen
bservational studies reporting risk-adjusted effects on
troke, OPCAB was associated with a significant reduction
n stroke (OR 0.62; 95% CI 0.55 to 0.69) (47,48,50,51,53–
1,63,65).
Nineteen RCTs reported 1 infarction, with an inci-
ence of 2.7% (n  70) (8–10,12,16,18,21,22,25,29,31–
5,37,41,42). Off-pump coronary artery bypass surgery non-
ignificantly reduced infarction (OR 0.79; 95% CI 0.50 to
.25). The number of observational studies reporting risk-
djusted effects on infarction was six (49,53,55,59,61,63).
hese studies showed OPCAB to be associated with sig-
ificantly reduced infarction rates (OR 0.66; 95% CI 0.50 to
.88).
The number of RCTs reporting 1 episode of atrial
brillation was 18, with an incidence of 22% (n  557)
8,9,14,16,20,22,24 –26,29,31,32,35,37,38,40,43). Off-
ump coronary artery bypass surgery caused a significant aeduction in atrial fibrillation (OR 0.59; 95% CI 0.46 to
.77), albeit with significant heterogeneity (p  0.09). This
eterogeneity was explained by stratification, according to
trial fibrillation rates in the control arms (Table 5). Strat-
fication also suggested that effects on atrial fibrillation
aried with the baseline incidence of the arrhythmia. In the
our observational studies reporting risk-adjusted effects on
trial fibrillation, OPCAB was associated with a statistically
ignificant reduction in atrial fibrillation (OR 0.78; 95% CI
.74 to 0.82) (53,57,59,67).
Off-pump coronary artery bypass surgery was also asso-
iated with favorable effects on other postoperative morbid
vents (Table 4). The only other statistically significant
enefits that were demonstrated in RCTs were reduced
notrope requirements and red cell transfusion. As with
trial fibrillation, stratification suggested that OPCAB’s
ffect on inotropic support varied with the baseline inci-
ence of inotrope use (Table 5).
ong-term outcomes. Five RCTs reported 1 long-term
one to two years) mortality (Table 4) (9,29,44,45). Off-
ump coronary artery bypass surgery was associated with
rends toward reduced long-term mortality (OR 0.82; 95%
I 0.40 to 1.68) and infarction (OR 0.61; 95% CI 0.32 to
.18). These improvements were, however, associated with
non-significantly increased need for repeat revasculariza-
ion (OR 1.75; 95% CI 0.78 to 3.94). The two observational
tudies reporting risk-adjusted effects on long-term out-
omes showed essentially no change in mortality (OR 1.01;
5% CI 0.74 to 1.40), non-significantly reduced infarction
OR 0.91; 95% CI 0.55 to 1.49), and trends toward
ncreased repeat revascularization (OR 1.35; 95% CI 0.76 to
.39) (53,64).
dequacy of revascularization. Twenty-four RCTs (2,284
ndividuals) reported the mean number of bypass grafts
8 –11,14 –16,20,21,24 –30,32–34,36 –38,40,43). Despite
andom allocation to OPCAB or CCAB, the mean graft
umber was 0.19 lower in the OPCAB arm. This difference
as statistically significant (95% CI: 0.25 lower to 0.13
ower; p  0.00001), without statistically significant heter-
geneity (p  0.15).
ensitivity analyses. Treatment effects were generally not
ffected by study quality or statistical model (Table 6).
ffects on mortality (OR 0.76; 95% CI 0.69 to 0.83) and
troke (OR 0.66; 95% CI 0.57 to 0.75) in large databases
ere similar to smaller datasets (mortality: OR 0.63, 95%
I 0.54 to 0.74; stroke: OR 0.54, 95% CI 0.46 to 0.66)
47,50,60).
ISCUSSION
reatment effects associated with OPCAB are generally
ore favorable in observational studies than in RCTs. The
agnitude of OPCAB’s effects in observational studies
xceeded that in RCTs for important short-term outcomes:
ortality, infarction, low-output syndrome, re-operation, andcute renal failure. Observational studies showed OPCAB to
Table 1. Characteristics of Included Randomized Controlled Trials That Assessed Off-Pump Coronary Artery Bypass Surgery (OPCAB)
Study
Patients
Randomized (n)
Mean Age
(Yrs)
Female
(%) Inclusion Criteria Location
Allocation
Concealment
Blinded Outcome
Assessment*
Patients
Analyzed (n)
Alwan et al. (8) 70 64 30 CABG France   70
Baker et al. (10) 26 64 19 CABG Australia   26
BHACAS 1 (9) 200 62 20 CABG UK   200
BHACAS 2 (9) 201 62 16 CABG UK   201
Caputo et al. (11)† 40 63 10 CABG UK   40
Carrier et al. (12) 65 70 23 CABG Canada   65
Covino et al. (13) 37 NR 11 CABG patients with chronic
lung disease
Italy   37
Czerny et al. (14) 80 64 16 CABG Austria   80
Diegler et al. (15) 40 50 NR CABG Germany   40
Gerola et al. (16) 160 59 34 CABG Brazil   160
Gu et al. (17) 62 61 34 CABG the Netherlands   62
Güler et al. (18) 58 55 NR CABG patients with chronic
lung disease
Turkey   58
Gulielmos et al. (19) 19 NR 26 CABG Germany   19
Johansson-Synnergren et al. (20) 52 62 35 CABG Sweden   52
Khan et al. (21) 104 63 13 CABG UK   103
Kochamba et al. (22) 58 59 23 CABG U.S.   58
Krejca et al. (23) 25 56 NR CABG Poland   25
Lee et al. (24) 60 66 23 CABG UK   60
Légaré et al. (25) 300 63 20 CABG Canada   300
Lingaas et al. (26) 120 65 22 CABG Norway   120
Matata et al. (27) 20 60 15 CABG UK   20
Motallebzadeh et al. (28) 35 64 9 CABG UK   35
Muneretto et al. (29) 176 67 37 CABG Italy   176
Parolari et al. (30) 25 61 24 CABG Italy   25
Penttilä et al. (31) 22 59 NR CABG Finland   22
Puskas et al. (32) 200 62 23 CABG U.S.   197
Sahlman et al. (33) 50 63 18 CABG Finland   50
Selvanayagam et al. (34) 60 61 13 CABG UK   60
Straka et al. (35) 400 NR 19 CABG Czech Republic   388
Tang et al. (36) 45 63 20 CABG UK   40
van Dijk et al. (37) 281 61 32 CABG the Netherlands   281
Velissaris et al. (38) 54 62 20 CABG UK   54
Vural et al. (39) 50 NR 12 CABG Turkey   50
Wan et al. (40) 37 65 30 CABG China   37
Wandschneider et al. (41) 119 66 21 CABG Austria   108
Wehlin et al. (42) 38 65 19 CABG Sweden   37
Zamvar et al. (43) 60 63 13 CABG UK   60
Total 3,449 3,416
*Double-blinding is not possible in OPCAB surgery trials. Some trials employed single-blinded protocols where outcome assessors were blinded to treatment allocation. †A third arm that was composed of OPCAB with a right ventricular
assist device was not included in analyses.
BHACAS  Beating Heart Against Cardioplagic Arrest Studies; CABG  coronary artery bypass graft; NR  not reported. 875
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Table 2. Characteristics of Included Observational Studies
Study n
Mean Age
(Yrs)
Female
(%)
Time
Period Location
Study
Centers Inclusion Criteria
OPCAB
Cases (%)
Deaths
(%)
Strokes
(%)
Al-Ruzzeh et al. (46) 305 52% 65 yrs 30 1999–2002 UK 1 Consecutive CABG cases with
left ventricular ejection fraction
 30%
106 (35%) 35 (11%) 13 (4%)
Aldea et al. (47) 8,402 66 27 1999–2000 U.S. 16 Consecutive CABG cases 1,233 (15%) 163 (2%) 150 (2%)
Ascione et al. (48) 4,077 64 19 1996–2001 UK 1 Consecutive CABG cases 923 (23%) 46 (1%) 45 (1%)
Boening et al. (49) 169 65 17 1998–2001 Germany 1 Consecutive CABG cases 72 (43%) 3 (2%) NR
Brown et al. (50) 16,871 69 100 1998–2001 U.S. 78 Consecutive females undergoing
CABG
2,631 (16%) 637 (4%) 286 (2%)
Bucerius et al. (2003) (51) 16,184 65 29 1996–2001 Germany 1 Consecutive cardiac surgery cases 1,842 (11%) NR 744 (5%)*
Bucerius et al. (2004) (52) 9,631 65 23 1996–2001 Germany 1 Consecutive CABG cases 761 (8%) 353 (4%) NR
Calafiore et al. (53) 1,020 70 28 1994–2001 Italy 1 Consecutive high-risk
CABG cases
510(50%) 46 (4%) 19 (2%)
Cheng et al. (54) 2,801 68 25 1995–2000 U.S. 4 Consecutive CABG cases 389 (14%) 143 (5%) 62 (2%)
Gaudino et al. (55) 306 71 47 1999–2002 Italy 1 Consecutive high-risk CABG
cases (Euroscore  5)
197 (64%) 19 (6%) 2 (1%)
Grunkemeier et al. (56) 3,110 67 27 1998–2001 U.S. 9 Consecutive CABG cases 990 (32%) NR NR
Hernandez et al. (57) 7,867 40% 70 yrs 29 1998–2000 U.S. 8 Consecutive CABG cases 1,741 (22%) 202 (3%) 135 (2%)
Hirose et al. (58) 1,490 65 24 1996–2001 Japan 2 Consecutive CABG cases 293 (13%) 15 (1%) 30 (2%)
Mack et al. (59) 11,548 64 27 1999–2001 U.S. 4 Consecutive CABG cases 5774 (50%) 327 (3%) 202 (2%)
Magee et al. (60) 204,602 66† 28 1999–2000 U.S. National-level
database
Consecutive multivessel
CABG cases
17,969 (9%) 5,862 (3%) 3,487 (2%)
Patel et al. (61) 10,941‡ 63 21 1997–2001 UK 4 Consecutive CABG cases 843 (8%) 252 (2%) NR
Plomondon et al. (62) 2,413 NR NR 1997–1999 U.S. 9 Consecutive CABG cases 680 (3%) 97 (4%) NR
Sabik et al. (63,64) 812 66 30 1997–2001 U.S. 1 Consecutive CABG cases 406 (50%) 6 (1%) 8 (1%)
Sharony et al. (65) 490 73 31 1993–2002 U.S. 1 CABG cases with severe
atheromatous disease in the
aorta
245 (50%) 41 (8%) 18 (4%)
Stallwood et al. (66) 2,199 64 20 2000–2002 UK 1 Consecutive CABG cases 716 (33%) NR NR
Tamis-Holland et al. (67) 209 66 27 1996–1999 U.S. 1 Randomly selected CABG cases 101 (48%) NR NR
Total 293,617
*Study sample included non-CABG cardiac surgery. †Median age for on-pump group. Median age for OPCAB group was 68 years. ‡Analyses involving effects on stroke encompassed 6,617 patients.
OPCAB  off-pump coronary artery bypass surgery. All other abbreviations as in Table 1.
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Table 3. Included Observational Studies: Quality of Reported Multivariable Modeling
Study Data Source
Statistical
Package
Reported
Odds Ratios &
Confidence
Intervals Listed
Included
Variables
Listed
Variable
Coding
Specified
Variable
Selection
Specified
Collinearity
Assessment
Interactions
Assessed
C-Statistic &
GOF* Tests
Ratio of Outcomes to
Covariates†
Death Stroke
Al-Ruzzeh et al. (46) Retrospective chart
review
        4 NR
Aldea et al. (47) Prospective database         6 5
Ascione et al. (48) Prospective database         NR 6
Boening et al. (49) NR  Propensity score
matching
      Propensity score
matching
Propensity score
matching
Brown et al. (50) Prospective database         6 2
Bucerius et al. (2003), (51) Prospective database         NR 68
Bucerius et al. (2004), (52) Prospective database         NR NR
Calafiore et al. (53) NR  Propensity score
matching
      Propensity score
matching
Propensity score
matching
Cheng et al. (54) Prospective database         16 12
Gaudino et al. (55) Prospective database         NR NR
Grunkemeier et al. (56) Prospective database         Stratified
propensity
score analysis
Stratified
propensity
score analysis
Hernandez et al. (57) Prospective database         16 10
Hirose et al. (58) Prospective database         NR NR
Mack et al. (59) Prospective database  Propensity score
matching
      Propensity score
matching
Propensity score
matching
Magee et al. (60) Prospective database         202 170
Patel et al. (61) Prospective database         18 NR
Plomondon et al. (62) Prospective database         5 NR
Sabik et al. (63,64) Prospective database  Propensity score
matching
      Propensity score
matching
Propensity score
matching
Sharony et al. (65) Prospective database  Propensity score
matching
      Propensity score
matching
Propensity score
matching
Stallwood et al. (66) Prospective database         NR NR
Tamis-Holland et al. (67) Retrospective chart
review
        NR NR
*Statistical goodness-of-fit tests (e.g., Hosmer-Lemeshow test). †Models with 10 outcome events to predictor variables may be biased (i.e., overfitted).
NR  not reported.
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Table 4. Treatment Effects of OPCAB on Mortality and Morbidity
Outcome
Randomized Controlled Trials Observational Studies
Studies
(Patients)
Odds Ratio
(95% CI)
p Value References
Heterogeneity
p Value
Studies
(Patients)
Odds Ratio
(95% CI)
p Value References
Heterogeneity
p Value
Short-term mortality 10 (3,254) 0.91 (0.45–1.83) (9,12,13,16,24–26,29,32,35) 0.87 14 (268,547) 0.72 (0.66–0.78) (46,47,49,50,53–55,57, 0.25
(30 days) p  0.79 p  0.00001 59–63,65)
Stroke 12 (2,968) 0.51 (0.25–1.05) (9,12,24–26,28,29,32,33,35,37) 0.96 15 (290,621) 0.62 (0.55–0.69) (47,48,50,51,53–61,63,65) 0.34
p  0.07 p  0.00001
Myocardial infarction 19 (2,963) 0.79 (0.50–1.25) (8–10,12,16,18,21,22,25,29,31–35,
37,41,42)
0.94 6 (24,796) 0.66 (0.50–0.88) (49,53,55,59,61,63) 0.93
p  0.32 p  0.004
Atrial fibrillation 18 (2,516) 0.59 (0.46–0.77)*† (8,9,14,16,20,22,24–26,29,31,32,
35,37,38,40,43)
0.09 4 (20,644) 0.78 (0.74–0.82) (53,57,59,67) 0.89
p  0.0001 p  0.0001
Inotrope requirement 16 (1,688) 0.48 (0.33–0.71)*† (8,9,11,13,16,18,25,31,33,34,
36–39,43)
0.06 NR NR NR
p  0.0003
Low cardiac output
syndrome
11 (1,352) 0.71 (0.44–1.15) (13,16,18,21,24–26,31,35,38–40) 0.74 3 (9,193) 0.62 (0.47–0.82) (53,55,57) 0.31
p  0.17 p  0.0009
Re-operation for
bleeding
8 (1,296) 0.90 (0.45–1.80) (14,21,22,25,26,32,33,35) 0.64 6 (31,964) 0.75 (0.41–1.38)*‡ (55,57,59,61,63,65) 0.00001
p  0.77 p  0.36
Acute renal failure 5 (1,107) 0.61 (0.25–1.47) (12,29,32,35,37) 0.75 8 (237,990) 0.54 (0.39–0.77)*‡ (47,52,55,59,60,63,65,66) 0.0001
p  0.27 p  0.0006
Red blood cell
transfusion
17 (2,387) 0.33 (0.21–0.53)*‡ (9,11,16,17,20–22,25,27,29,32,35,
37,39,42,43)
0.00001 2 (1,832) 0.62 (0.50–0.76) (53,63) 0.69
p  0.00001 p 0.00001
Long-term outcomes
Long-term mortality
(1–2 yrs)
5 (1,050) 0.82 (0.40–1.68) (9,29,44,45) 0.94 2 (1,832) 1.01 (0.74–1.40) (53,64) 0.50
p  0.59 p  0.93
Myocardial infarction
(1–2 yrs)
5 (1,050) 0.61 (0.32–1.18) (9,29,44,45) 0.97 2 (1,832) 0.91 (0.55–1.49) (53,64) 0.85
p  0.14 p  0.70
Revascularization (1–2
yrs)
5 (1,050) 1.72 (0.78–3.94) (9,29,44,45) 0.82 2 (1,832) 1.35 (0.76–2.39) (53,64) 0.71
p  0.17 p  0.31
*Random effects model employed due to statistically significant heterogeneity (p 0.10). †Heterogeneity explained by stratified analysis (Table 5). ‡Subgroup analyses did not explain the heterogeneity in this analysis.
CI  confidence interval. All other abbreviations as in Table 1.
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side from re-operation for bleeding. In contrast, RCTs
emonstrated statistically significant benefits for only two
utcomes (atrial fibrillation, red cell transfusion).
Importantly, RCTs did not show OPCAB to reduce
ortality; even the observed trend was not impressive.
ll-cause mortality is an important outcome: as a “hard”
utcome, it was less sensitive to the absence of blinded
utcome assessment in most RCTs. Although the trend
oward reduced stroke in RCTs is promising, this potential
ust be tempered by the general absence of blinded outcome
djudication and standardized stroke assessment protocols.
In contrast, OPCAB’s mortality benefit in observational
tudies was statistically significant and 20% greater in
agnitude. All-cause mortality is likely the most robust
utcome in observational studies, given that these studies
acked blinded outcome assessment and systematic outcome
urveillance. There are several possible reasons for this
iscrepancy between RCTs and observational studies. First,
tatistical significance in observational studies is driven by
he much larger sample size. Second, risk-adjustment tech-
iques might have failed to adequately adjust for the
ifferences between patients who underwent OPCAB as
pposed to CCAB. Third, up to 13% of attempted OPCAB
rocedures are converted intraoperatively to CCAB (68).
iven that urgent conversion is associated with mortality
nd morbidity, OPCAB’s benefits might be exaggerated
able 5. Post Hoc Stratified Analyses That Employed Data From
Outcome
Incidence of Outcome
in Control Arm
Studies
(Patients)
trial fibrillation All studies 18 (2,516)
trial fibrillation 25% 8 (1,327)
trial fibrillation 26%–44% 8 (937)
trial fibrillation 45% 2 (252)
notrope requirement All studies 16 (1,688)
notrope requirement 20% 7 (848)
notrope requirement 20% 9 (840)
able 6. Effect of Study Quality and Statistical Model on Estima
Type of Study Outcome
All Studie
Odds Ratio
(95% CI)
andomized controlled
trial
Mortality (short-term) 0.91 (0.45–1.83)
bservational Mortality (short-term) 0.72 (0.66–0.78)
andomized controlled
trial
Stroke 0.51 (0.25–1.05)
bservational Stroke 0.62 (0.55–0.69)
andomized controlled
trial
Myocardial infarction 0.79 (0.50–1.25)
bservational Myocardial infarction 0.66 (0.50–0.88)
andomized controlled
trial
Atrial fibrillation 0.59 (0.46–0.77)
bservational Atrial fibrillation 0.78 (0.74–0.82)
Randomized controlled trials with clear allocation concealment (8,9,11,24,25,2
51,53,54,56,57,59–61,63,65). †Original analysis employed the random effects model.
CI  confidence interval.f converted procedures were coded as CCAB in clinical
egistries (68). Finally, mortality benefits seen in RCTs
ight have been diminished because most recruited
ndividuals were low-risk. The 1.7% mortality rate re-
orted in the CCAB arms of RCTs is approximately
ne-half the average North American rate (1). As sug-
ested by OPCAB’s effects on atrial fibrillation and ino-
rope requirement, its effect on mortality might be enhanced
mong higher-risk patients.
Both RCTs and observational studies raise important
uestions about OPCAB’s long-term effects. Both study
ypes demonstrated that OPCAB was associated with
rends toward increased repeat revascularization. In the
ontext of significantly fewer grafts with OPCAB, future
tudies must address the frequency of repeat revasculariza-
ion with OPCAB. This end point is likely more relevant to
atients than assessments of graft patency.
Several previous systematic reviews have addressed OPCAB
utcomes (54,69–74). Most focused only on RCTs or
pecific outcomes (69–72,74). Except for Cheng et al. (75),
ur study included more RCTs than did previous reviews.
eston et al. (73) was the only previous study to consider
ata from RCTs and observational studies for several
utcomes; however, observational studies were not restricted
o risk-adjusted ones. Although Reston et al. (73) suggest
hat including non-adjusted studies did not exaggerate
PCAB’s benefits, our results suggest otherwise. Their
ndomized Trials
Odds Ratio
(95% Confidence Intervals) p Value
Heterogeneity
p Value
0.59 (0.46–0.77) 0.0001 0.09
0.84 (0.62–1.13) 0.24 0.95
0.57 (0.43–0.75) 0.0001 0.74
0.20 (0.11–0.37) 0.0001 0.14
0.48 (0.33–0.71) 0.0003 0.06
0.87 (0.58–1.30) 0.49 0.67
0.35 (0.23–0.54) 0.0001 0.28
reatment Effects
High-Quality Studies* Random Effects Model
alue
Odds Ratio
(95% CI) p Value
Odds Ratio
(95% CI) p Value
9 0.83 (0.25–2.75) 0.77 0.96 (0.45–2.04) 0.91
0001 0.69 (0.57–0.83) 0.0001 0.69 (0.61–0.79) 0.00001
7 0.69 (0.29–1.67) 0.41 0.51 (0.23–1.11) 0.09
0001 0.61 (0.55–0.68) 0.00001 0.60 (0.53–0.69) 0.00001
2 0.88 (0.45–1.74) 0.41 0.81 (0.49–1.33) 0.40
04 0.65 (0.48–0.87) 0.003 0.66 (0.50–0.88) 0.004
001 0.50 (0.33–0.75) 0.0008 0.59 (0.46–0.77)† 0.0001
001 0.78 (0.74–0.82) 0.00001 0.78 (0.74–0.82) 0.00001
2,37,40,43) or observational studies with adequate risk-adjustment techniquesRated T
s
p V
0.7
0.0
0.0
0.0
0.3
0.0
0.0
0.0
8,31,3
e
0
0
a
u
f
5
s
a
l
t
u
t
o
a
i
o
t
(
R
o
s
O
s
r
s
g
t
c
r
a
a
r
m
t
i
e
o
r
o
c
t
e
m
m
i
C
a
s
v
b
r
F
O
S
C
o
f
e
R
s
2
R
1
1
1
1
1
1
1
1
880 Wijeysundera et al. JACC Vol. 46, No. 5, 2005
Meta-Analysis of Off-Pump Coronary Artery Surgery September 6, 2005:872–82stimated effect on short-term mortality (OR 0.64; 95% CI
.54 to 0.75) is larger than our estimate for both RCTs (OR
.91) and observational studies (OR 0.72).
This review identifies important deficiencies in the liter-
ture that must be addressed by future RCTs. Trials remain
nderpowered to detect clinically important treatment ef-
ects. Assuming a 2% baseline stroke rate, approximately
,000 patients would be required to detect the effect
uggested by our study (alpha 0.05, power 80%) (60). In
ddition, patients enrolled in trials thus far were generally
ow-risk. This patient profile reduces the generalizability of
he results, necessitates larger sample sizes, and might
nderestimate OPCAB’s benefits among higher-risk pa-
ients. Further improvements remain needed in the quality
f RCTs. Most previous trials did not adequately conceal
llocation or blind outcome assessors, both of which can
nfluence estimated treatment efficacy (76). Blinding of
utcome assessors is also integral to confirming our finding
hat OPCAB might prevent non-fatal morbid events
stroke, atrial fibrillation, inotropic support). Finally, more
CTs must address longer-term outcomes. The importance
f these data cannot be overstated.
In the absence of large RCTs, risk-adjusted observational
tudies constitute the majority of the evidence supporting
PCAB’s benefits. Observational research within cardiac
urgery has been facilitated by prospective databases with
igorous quality control and follow-up. Observational re-
earch has important advantages. The results might be more
eneralizable: patients and surgeons included in observa-
ional studies are more similar to those encountered in
linical practice. Randomized controlled trials generally
ecruit low-risk patients who undergo surgery performed by
few experienced surgeons. Given that most perioperative
dverse events are uncommon, adequately powered RCTs
emain large and expensive. Observational studies are a
ore economical method for evaluating OPCAB’s effec-
iveness.
These advantages, however, are counter-balanced by
mportant limitations. Unmeasured confounders might bias
ven well-analyzed cohort studies; therefore, meta-analyses
f observational data might produce precise but spurious
esults (77). In addition, interpretation of results from
bservational studies should be limited to associations; no
ausal inferences should be drawn. Despite these limita-
ions, there remains a role for observational research in
stablishing the effectiveness of OPCAB. Future studies
ust report more transparent analytic plans, account for
isclassification of converted OPCAB procedures, and
ncorporate longer-term outcomes.
onclusions. Randomized controlled trials did not find,
side from atrial fibrillation, the significant reductions in
hort-term mortality and morbidity demonstrated by obser-
ational studies. These discrepancies are explained, in part,
y differing patient selection and study methodology. This
eview identifies three important goals for future studies.
irst, research methodology must be improved to clarifyPCAB’s potential for preventing non-fatal morbid events.
econd, long-term data are required to understand OP-
AB’s association with repeat revascularization. Finally, as
pposed to recruiting low-risk individuals, studies should
ocus on patients at increased risk for perioperative morbid
vents.
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